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Chapter 33
Galleria mellonella as a Model for Fungal  
Pathogenicity Testing
John Fallon, Judy Kelly, and Kevin Kavanagh
Abstract
Insects are convenient models for assessing the virulence of microbial pathogens or for assessing the  efficacy 
of antimicrobial drugs and give results comparable to those that can be obtained using mammals. Galleria 
mellonella larvae are easy to purchase and inoculate and provide results within 48 h. Various parameters 
may be used to monitor the effect of a pathogen on the insect and, as a consequence, measure its relative 
virulence. Larval death, changes in immune cells (haemocytes) numbers, or the extent of proliferation of 
the pathogen within the insect haemocoel are good indicators of virulence and of the insect’s immune 
response. Analysing the humoral immune response also gives insight into the interaction of the pathogen 
with the insect. Changes in gene expression or the expression of key antimicrobial peptides provide data 
on this element of the insect’s response and, through extrapolation, how the mammalian immune system 
might respond. G. mellonella larvae, therefore, provide a quick and convenient means of measuring micro-
bial virulence and are a useful alternative to the use of mammals for this type of screening.
Key words: Aspergillus, Candida, Fungi, Galleria, Haemocytes, Microbial virulence, Mini-host
The insect immune system shares a number of structural and func-
tional similarities with the mammalian innate immune system and, 
as a consequence, insects may be used in place of mammals for 
screening microbial pathogens or for assessing the potency of anti-
microbial drugs (1). Larvae of the greater wax moth Galleria mel-
lonella are inexpensive to purchase, easy to inoculate, and can give 
results within 48 h. We have employed G. mellonella larvae to assess 
the virulence of yeast (2) and Aspergillus fumigatus (3), with strong 
correlations between the virulence in larvae and mice of Candida 
albicans (4) and Cryptococcus (5) demonstrated. The use of insects 
as a screening model is now well established for many pathogens 
1. Introduction
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(4–6), with Galleria and other insects, such as Drosophila and 
Manduca, often referred to as “mini-hosts” (7, 8).
Changes in G. mellonella larva viability can be used to measure 
the relative virulence of microbial pathogens and/or mutants. 
Monitoring the insect immune response to microbial pathogens 
can also be useful as this gives an insight into the virulence of 
“weak” pathogens and provides information on how the mamma-
lian innate immune system may respond. Measuring changes in the 
haemocyte density and the fungal load gives information on the 
cellular immune response to the pathogen and the proliferation of 
the pathogen in the host, respectively (9). In addition, it is also 
possible to monitor the expression of genes for selected antimicro-
bial peptides as a means of assessing the humoral immune response 
of larvae (10). Analysing changes in the proteome of infected lar-
vae can also be very useful for monitoring alterations in expression 
of low molecular weight antimicrobial peptides. We have used this 
latter technique to demonstrate that larvae mount a “proportion-
ate” immune response when inoculated with pathogen-derived 
material (11).
Insects are also a useful in vivo screening system for assessing 
the potency of antimicrobial agents (12–15). In this application, 
larvae can be infected with the cells or conidia of a pathogen and 
then given a pre-determined dose of the antimicrobial agent. An 
alternative is possible where the larvae are given the agent in 
advance of the pathogen. It should be emphasised, however, that 
administration of an antimicrobial agent to larvae induces a protec-
tive immune response and that any protective effect could be due 
to the combined effect of the antimicrobial agent and the insect’s 
enhanced immune response (15). Controls to account for the 
increased immune response of the insect must be included in order 
to see the actual effect of the drug in vivo.
The use of insects as in vivo models to assess fungal virulence 
has grown in popularity in recent years (1, 7, 8). Although there 
are many advantages to the use of insects, G. mellonella larvae in 
particular, it must be emphasised that the insect immune system is 
only analogous to the mammalian innate immune system, and 
therefore, insect models give no insight into the role of the adap-
tive immune system in combating infections in mammals. In addi-
tion, larvae lack many of the organs attacked specifically by fungal 
pathogens, e.g. brain, lungs, kidneys, and spleen, so they cannot be 
used to model organ-specific pathologies. However, G. mellonella 
does provide a convenient initial screening system for studying 
pathogens that cause systemic infection, although as with all mini-
hosts, validation of results may require further confirmatory mam-
malian testing.
This chapter describes a range of methods for use with G. mel-
lonella larvae for evaluating the virulence of fungal pathogens or 
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33 Galleria mellonella Fungal Model
for assessing the efficacy of antimicrobial agents. It details techniques 
for measuring the effect of the pathogen or drug on the insect 
immune response and describes methods for quantifying the 
response of the larvae to the different agents.
 1. Sixth instar Galleria mellonella larvae (Lepidoptera: pyralidae, 
greater wax moth) (Mealworm Company) (see Note 1).
 2. Myjector syringe (Terumo Europe).
 3. YEPD (2% (w/v) glucose (Sigma-Aldrich), 2% (w/v) bacto 
peptone (Difco), 1% (w/v) yeast extract (Oxoid)).
 4. Stationary phase culture of Candida albicans (1–2 × 109 cells/
mL) grown in YEPD at 30°C and 200 rpm.
 5. Phosphate buffered saline (PBS).
 6. Petri dishes (9 cm).
 7. Filter paper circles (9 cm).
 1. Infected and control G. mellonella larvae.
 2. Sterile needles (23 G, Terumo).
 3. Sterile tubes (1.5 mL).
 4. 1-Phenyl-3-(2-thiazolyl)-2-thiourea.
 5. Ice-cold PBS containing 0.37% (v/v) 2-mercaptoethanol.
 6. Haemocytometer.
 7. Microscope.
 1. Sixth instar G. mellonella larvae.
 2. Stationary phase culture of C. albicans.
 3. Sterile (pre-autoclaved) pestle and mortar.
 4. PBS.
 5. YEPD-erythromycin agar plates: 2% (w/v) glucose, 2% (w/v) 
bacteriological peptone, 1% (w/v) yeast extract, and 2% (w/v) 
agar and 1 mg/mL erythromycin (Sigma-Aldrich).
 1. C. albicans-infected G. mellonella larvae.
 2. Caspofungin (Cancidas™, Merck & Co.).
 3. PBS.
 4. Petri dishes (9 cm).
 5. Filter paper circles (9 cm).
2. Materials
2.1. Inoculation  
of Galleria mellonella 
Larvae with Candida 
albicans
2.2. Determination  
of Haemocyte Density 
of Galleria mellonella
2.3. Determination  
of Candida albicans 
Fungal Load  
in Infected Galleria 
mellonella Larvae
2.4. Assessment  
of Caspofungin In Vivo 
Activity Against 
Candida albicans
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 1. Sixth instar G. mellonella larvae.
 2. Sterile (RNase-free) pestles and mortars.
 3. Liquid nitrogen.
 4. Sterile tubes (1.5 mL).
 5. TRI® Reagent (Sigma-Aldrich).
 6. Vortex mixer.
 7. Chloroform.
 8. Isopropanol.
 9. 75% (v/v) ethanol.
 10. DEPC-treated water.
 11. Deoxyribonuclease I (AMP-D1) kit (Sigma-Aldrich).
 12. RNase-free agarose.
 13. 10× FA buffer (200 mM 3-(N-morpholino)propanesulfonic 
acid (MOPS), 50 mM sodium acetate, 10 mM EDTA, pH 7).
 14. 37% (v/v) formaldehyde.
 15. 0.5% (w/v) SDS.
 16. 10 mg/mL ethidium bromide.
 17. Agarose gel electrophoresis equipment.
 18. 5× RNA gel loading dye (for 10 mL: 80 ML 0.5 M EDTA, pH 
8, 720 ML 37% (v/v) formaldehyde, 2 mL glycerol, 3.084 mL 
formamide, 4 mL 10× FA buffer, and 16 ML saturated aqueous 
bromophenol blue solution).
 19. 1× TAE buffer (1/50 dilution of 50× stock: 24.2% (w/v) Tris-
base, 5.71% (v/v) acetic acid, 0.05 M EDTA (pH 8)).
 20. Nanodrop 1000 spectrophotometer.
 21. Superscript III First-Strand Synthesis System (Invitrogen).
 22. DMSO (molecular grade).
 23. 10 mM dNTP mix (Promega).
 24. Water (molecular grade).
 25. Accutaq™ LA DNA polymerase.
 26. 10 MM forward and reverse primers (Table 1, (10)).
 27. Thermal cycler.
 28. Blue/orange 6× loading dye (Promega).
 1. Pre-chilled (−20°C) 1.5-mL tubes.
 2. Sterile deionised water.
 3. Bradford reagent.
 4. IEF Buffer (8 M urea, 2 M thiourea, 4% (v/v) CHAPS, 1% 
Triton-X 100, 65 mM DTT, 10 mM tris base).
2.5. Extraction of 
Galleria mellonella 
RNA and Antimicrobial 
Gene Expression 
Analysis
2.6. Analysis of 
Proteomic Changes in 
Infected Larvae by 2D 
Gel Electrophoresis 
and LC/MS
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33 Galleria mellonella Fungal Model
 5. IPG Buffer (ampholytes) pH 3–10 (GE Healthcare).
 6. Bromophenol blue powder.
 7. Iso-electric focusing (IEF) machine (Ettan IPGphor II, 
Amersham Biosciences).
 8. IEF coffins (Amersham Biosciences).
 9. IEF strips (GE Healthcare).
 10. PlusOne strip cover fluid (GE Healthcare).
 11. Test tubes (at least 13 cm long).
 12. Dithiothreitol (DTT).
 13. Iodoacetamide (IAA).
 14. Equilibration buffer (30% glycerol, 2% SDS, 6 M urea, 50 mM 
tris base).
 15. 1.5 M Tris–HCl, pH 8.8.
 16. 10% SDS, filter-sterilised and stored at room temperature to 
prevent crystallisation.
Table 1 
PCR primers and conditions for analysis of antimicrobial gene expression
Gene Primer Sequence 5c-3c Product size (bp) PCR conditions
Actin ACT1F GGGACGATATGGAG 
AAGATCTG
400
ACT1R CACGCTCTGTGAG 
GATCTTC
1 cycle: 98°C, 2 min
Transferrin TRANSF CCCGAAGATGAA 
CGATCAC
535
TRANSR CGAAAGGCCTAG 
AACGTTTG
35 cycles: 94°C, 
1 min; 55°C, 
1 min; 72°C, 
1.5 min
IMPI IMPIF ATTTGTAACGGT 
GGACACGA
409
IMPIR CGCAAATTGGT 
ATGCATGG
1 cycle: 72°C, 10 min
Galiomicin GALIOF CCTCTGATTGCA 
ATGCTGAGTG
359
GALIOR GCTGCCAAGTTA 
GTCAACAGG
Final hold: 10°C
Gallerimycin GALLERF GAAGATCGCTT 
TCATAGTCGC
175
GALLERR TACTCCTGCAGT 
TAGCAATGC
Primer sequences are taken from Bergin et al. (2007) (10)
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[AU2]
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 17. 30% acrylamide.
 18. 10% ammonium persulphate.
 19. N,N,N,N c-Tetramethyl-ethylene diamine (TEMED).
 20. SDS-PAGE standards (Bio-Rad).
 21. 1× Running buffer (1 in 10 dilution of 10× stock: 30 g Trizma 
base, 144 g glycine, 10 g SDS in 1 L distilled water).
 22. Agarose.
 23. Coomassie stain.
 24. Siliconised 1.5-mL centrifuge tubes washed with 100% 
acetonitrile.
 25. Sterile scalpels or pipette tips washed in 100% methanol (scal-
pels should be used to excise larger spots or bands, with sterile 
pipette tips useful for excising smaller gel pieces).
 26. Destaining buffer (100 mM ammonium bicarbonate 
(NH4HCO3): acetonitrile; 1:1).
 27. 100% acetonitrile.
 28. Trypsin digestion buffer (13 ng/ML sequencing grade trypsin 
(Promega) in 10 mM NH4HCO3, 10% (v/v) acetonitrile).
 29. Extraction buffer (1:2 (v/v) 5% formic acid: 100% acetonitrile).
 30. 0.1% formic acid made using LC/MS-grade water.
 31. 0.22-Mm cellulose filter tubes.
 32. Liquid chromatography-mass spectrometry (LC-MS).
 1. Peptide extraction buffer (HPLC grade methanol:glacial acetic 
acid: HPLC grade water, 9:0.1:0.9); chilled on ice prior to use.
 2. Freeze drier for lyophilisation.
 3. 0.1% (v/v) trifluoroacetic acid (TFA) made in HPLC-grade 
water.
 4. n-Hexane.
 5. Ethyl acetate.
 6. Bradford reagent (Biorad).
 7. 1.5-mL tubes.
 1. Place ten healthy larvae on Whatman filter paper placed in 
sterile 9-cm Petri dishes.
 2. Grow a C. albicans culture to stationary phase (1–2 × 109/mL) 
in YEPD broth at 30°C, with shaking at 200 rpm. Harvest 
cells by centrifugation (2,056 × g for 5 min), wash in PBS and 
2.7. Extraction and 
Analysis of Peptides 
from Galleria 
mellonella Larvae
3. Methods
3.1. Inoculation of 
Galleria mellonella 
Larvae with Candida 
albicans
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33 Galleria mellonella Fungal Model
re-suspend in PBS at various cell densities, ranging from 5 × 105, 
1 × 106, 2.5 × 106 to 5 × 106 per 20 ML (see Note 2).
 3. Inoculate larvae by injecting 20 ML through the last left proleg 
into the haemocoel using a Myjector syringe (Fig. 1) and place 
at 30°C in the dark for up to 96 h (see Note 3). Untouched 
larvae and larvae injected with 20 ML of water or PBS should 
be included as controls.
 4. Assess larvae at regular intervals (every 2 h) for viability and 
disease progression. For assessment of viability, larvae should 
be gently probed with a needle, and if no response is observed, 
the larvae may be considered to be dead. Changes in cuticle 
melanisation can also be used to monitor the severity of an 
infection (Fig. 2) (see Note 4).
Fig. 1. Inoculation of Galleria mellonella larvae by injection through the proleg.
Fig. 2. Larval morphology. (a) Healthy Galleria mellonella larvae. (b) Larvae killed as a result of Aspergillus fumigatus infec-
tion 48 h previously. Note the dark colour of cadavers due to melanisation.
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 1. Pierce the backs of the anterior end (“head”) of three ran-
domly chosen larvae with a sterile needle and collect the yellow 
haemolymph (“blood”) into a single pre-chilled tube contain-
ing a few grains of 1-phenyl-3-(2-thiazolyl)-2-thiourea (see 
Notes 5 and 6).
 2. Dilute haemolymph 1 in 10 in cold PBS containing 0.37% 
(v/v) 2-mercaptoethanol to reduce clotting and melanisation. 
Mix gently by pipetting.
 3. Count haemocytes on a haemocytometer (Fig. 3) and calculate 
the original density in the larvae (see Note 7).
 1. Inoculate ten G. mellonella larvae with C. albicans 
(5 × 105 cells/20 ML) and incubate for 24 h at 30°C.
 2. Select three random larvae and place in a sterile pestle with 
3 mL PBS and grind to a pulp with a mortar.
 3. Dilute the resulting homogenate with PBS and plate 100-ML 
samples onto YEPD-erythromycin plates (see Notes 8 and 9).
 4. Incubate plates at 30°C for 24 h and enumerate colony-forming 
units.
 5. Calculate larval fungal load by multiplying the colony-forming 
units by the relevant dilution factor (see Note 10).
 1. Infect G. mellonella larvae with C. albicans as described above 
(see Note 11), including relevant control groups (see Note 12).
 2. At 1 h post-infection, inoculate larvae with a 20-ML volume of 
caspofungin (e.g. 0.2, 0.1, or 0.05 Mg/mL) or PBS (as con-
trol). Place at 30°C for up to 96 h.
3.2. Determination  
of Haemocyte Density 
of Galleria mellonella
3.3. Determination  
of Fungal Load  
of Galleria mellonella 
Inoculated with 
Candida albicans
3.4. Assessment  
of In Vivo Activity  
of Caspofungin  
in C. albicans-Infected 
G. mellonella
Fig. 3. G. mellonella haemocytes. G. mellonella haemocytes were extracted and viewed by 
light microscopy (40× objective). Note variations in size and granularity.
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33 Galleria mellonella Fungal Model
 3. Assess larval viability at 24-h intervals.
 4. As an alternative to assess the effectiveness of caspofungin, 
inject larvae with caspofungin 1 or 4 h prior to infection with 
C. albicans.
For RNA extractions, RNase-free materials should be used and pre-
cautions taken to minimise RNase contamination (see Note 13).
 1. Place three G. mellonella larvae in a mortar (see Note 14); 
cover with liquid nitrogen (about 5 mL). Grind with a pestle 
until the larvae resemble a fine powder.
 2. Add 3 mL TRI® reagent and mix. Leave to rise slightly in tem-
perature until liquid becomes less viscous.
 3. Transfer liquid to 1.5-mL tubes (1 mL in each) and centrifuge 
at 12,000 × g for 10 min at 4°C.
 4. Transfer the supernatant to a new tube. Do not pool superna-
tants. To each tube, add 200 ML chloroform and vortex for 
15 s. Leave to stand at room temperature for 10 min.
 5. Centrifuge tubes as before and transfer the upper layer to a 
new tube and add 500 ML isopropanol. Invert the tubes several 
times and allow to stand at room temperature for 10 min.
 6. Centrifuge tubes as before. Discard the supernatant and wash 
the pellet in 100 ML 75% ethanol by vortexing. Centrifuge 
tubes as before and remove ethanol completely. Allow tubes to 
air dry by placing in a Laminar flow hood on ice.
 7. Re-suspend the pellet in 80 ML DEPC-treated water.
 8. Remove contaminating DNA using the deoxyribonuclease I 
(AMP-D1) kit in accordance with the manufacturer’s instruc-
tions to DNase treat samples.
 9. Determine RNA concentration using the Nanodrop 1000 
spectrophotometer.
 10. Aliquot RNA and store at −80°C.
 11. Prior to use, wash the gel rig and tank with 0.5% (w/v) SDS, 
rinse with DEPC-treated water followed by ethanol, and allow 
to air dry.
 12. In order to visualise RNA, prepare 100 mL of 1% (w/v) aga-
rose in 1× FA buffer. Heat the mixture until dissolved and 
allow to cool to hand-hot. Add 1.8 mL 37% (v/v) formalde-
hyde plus 1 ML of 10 mg/ml ethidium bromide prior to pour-
ing the gel.
 13. Prior to running, equilibrate the gel in 1× FA running buffer 
for at least 30 min.
 14. Add 4 ML RNA to 4 ML 5× RNA gel loading dye; heat to 65°C 
for 5 min and chill on ice.
3.5. Extraction  
of Galleria mellonella 
RNA and Antimicrobial 
Gene Expression 
Analysis
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 15. Load the samples into the wells of the gel and run at 50 V in 
1× FA buffer for approximately 40 min. Visualise bands using 
a UV transilluminator.
 16. Synthesise cDNA using 1 Mg RNA and the Superscript III 
First-Strand Synthesis System for RT-PCR kit according 
to manufacturer’s instructions. cDNA should be stored 
at −20°C.
 17. Analyse expression of G. mellonella antimicrobial genes by 
qRT-PCR using primers and PCR cycle conditions outlined in 
Table 1. The Actin housekeeping gene can be used as a con-
trol. Each PCR reaction (20 ML volume) contains 1 Mg/ML 
cDNA, 2 ML 10× LA Buffer, 0.4 ML DMSO, 1 ML 10 mM 
dNTP mix, 14.6 ML water, 0.4 ML 10 MM forward primer, 
0.4 ML 10 MM reverse primer, and 0.2 ML AccuTaq™ LA DNA 
polymerase. Solutions were mixed by pipetting and placed 
immediately into the thermal cycler.
 18. Mix 4 ML of PCR product with 4 ML blue/orange 6× loading 
dye.
 19. Visualise PCR products by running samples on a 1% (w/v) 
agarose gel (1 g agarose in 100 mL 1× TAE) with the addition 
of 2 ML 10 mg/mL ethidium bromide. Run gel at 50 V for 
30 min and view using a UV transilluminator (Fig. 4).
The gel fragment tryptic digestion part of the protocol is a modifi-
cation of the method described by Schevchenko et al. (17).
 1. Bleed ten fungal-infected G. mellonella larvae into a pre-chilled 
1.5-mL tube (as in subheading 3.2) and centrifuge at 800 × g 
for 2 min at 4°C to pellet haemocytes. Transfer the cell-free 
supernatant to a fresh tube.
 2. Make a 1 in 50 dilution of the crude cell-free haemolymph in 
deionised water and quantify protein content using Bradford 
method as per the manufacturer’s instructions. Calculate the 
protein concentration of the neat cell-free haemolymph.
3.6. Analysis of 
Proteomic Changes in 
Infected Larvae by 2D 
Gel Electrophoresis 
and LC/MS
Fig. 4. Visualisation of antimicrobial gene expression. RNA extracted from infected larvae 
was used as the template for cDNA synthesis and subsequent PCR reactions to examine 
expression of antimicrobial peptide genes; (1) larvae injected with PBS, (2) larvae injected 
with 0.19 Mg/mL caspofungin, (3) larvae injected with 0.095 Mg/mL caspofungin, and 
(4) larvae injected with 0.048 Mg/mL caspofungin.
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 3. Add 350 Mg protein to 100 ML IEF buffer and allow to solubi-
lise for approximately 15 min at room temperature.
 4. Add 2 ML ampholytes, pipette four to five times to mix, and 
allow to stand at room temperature for 15 min.
 5. Add a further 150 ML IEF buffer and add a few grains of bro-
mophenol blue to the solution and mix by pipetting.
 6. Pipette 250 ML of the sample into an IEF coffin, tilt the IEF cof-
fin to ensure an even distribution, and place a 13-cm IEF strip 
on top. Cover the strip with PlusOne DryStrip Cover Fluid.
 7. Place the coffins into the IEF machine. Apply the following 
strip-focusing method per strip: 12 h at 50 V, 15 min at 250 V, 
increasing to 8,000 V with gradient increase over 5 h, and then 
hold at 8 h at 8,000 V. Once focusing is complete, strips may be 
stored at −70°C with the gel side of IEF strip facing upwards.
 8. Aliquot 10 mL equilibration buffer into two separate test tubes. 
Dissolve 0.2 g DTT in the first equilibration tube and 0.4 g 
iodoacetamide in the second equilibration tube. Add a few 
grains of bromophenol blue to the second equilibration tube.
 9. Transfer the IEF strip to the first equilibration solution, seal 
with paraffin film, and incubate horizontally on a rocking table 
for 15 min.
 10. Transfer to the second equilibration solution and allow to 
equilibrate as in step 9.
 11. Once equilibration is complete, rinse briefly with deionised 
water and place on top of the separating gel (see Note 15). 
Prepare a gel for 2D electrophoresis (see Note 16).
 12. Place a piece of filter paper soaked in SDS-PAGE ladder at the 
corner of the gel and seal with a 1% agarose solution made with 
1× SDS-PAGE running buffer.
 13. Run gel at 80 V overnight and stain with Coomassie stain 
(Fig. 5).
 14. Cut gel pieces from 2D gels (see Note 17) and transfer to indi-
vidual siliconised tubes.
 15. Wash stain from the gel piece using destaining buffer (200 ML) 
at room temperature and vortex occasionally. Repeat this step 
if required to remove all of the stain (see Note 18).
 16. Remove all of the destaining buffer and resuspend the gel 
pieces in sufficient 100% acetonitrile to cover the gel piece (see 
Note 19).
 17. Remove the acetonitrile. At this point, gel pieces can be stored 
at −20°C; alternatively proceed to step 20.
 18. Add 60 ML trypsin digestion buffer to each tube containing gel 
pieces.
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 19. Place all tubes on ice for 30 min (see Note 20).
 20. Add sufficient trypsin buffer to cover the gel pieces and keep 
on ice for approximately 60 min. Inspect all tubes to ensure 
that all the gel pieces remain covered.
 21. Add 10 mM AmBic:10% vol/vol buffer to ensure that the gel 
plug is hydrated during enzymatic cleavage (see Note 21).
 22. Incubate tubes at 37°C for 4–24 h to allow for tryptic diges-
tion of protein (see Note 22).
 23. Centrifuge the tryptic digests at 5,000 × g for 5 min and trans-
fer the supernatant to a clean tube.
 24. Add approximately 100 ML extraction buffer to the remaining gel 
piece pellet and incubate at 37°C for 15 min to extract peptides.
 25. Centrifuge and transfer the supernatant to the tryptic diges-
tion supernatant from step 23.
 26. Vacuum dry the pooled supernatants to completion.
 27. Store at −20°C until required for LC/MS analysis.
 28. Prior to LC/MS analysis, resuspend the dried supernatants in 
15 ML 0.1% formic acid and remove any debris by adding to a 
0.22-Mm cellulose acetate filter and centrifuging the tube at 
20,000 × g for 3 min.
 29. Transfer 10 ML of each sample to an LC/MS vial for analysis 
(see Note 23).
Peptide extraction is performed by the method of Cytrynska et al. 
(16) with slight modifications.
 1. Bleed ten larvae into a pre-chilled 1.5-mL tube and centrifuge 
at 800 × g for 2 min at 4°C to pellet haemocytes. Transfer the 
cell-free supernatant to a fresh tube.
3.7. Extraction and 
Analysis of Peptides 
from G. mellonella 
Larvae
Fig. 5. G. mellonella larval haemolymph proteome. A control larvae and proteome of larvae 
challenged with beta-glucan. Note the increased expression of spots corresponding to 
specific proteins.
#%&
#%'
#%(
#%)
#&*
#&!
#&"
#&#
#&$
#&%
#&&
#&'
#&(
#&)
#'*
#'!
#'"
#'#
#'$
#'%
#'&
#''
#'(
#')
#(*
#(!
#("
33 Galleria mellonella Fungal Model
 2. Make a 1/10 dilution of cell free haemolymph in peptide 
extraction buffer and leave to stand on ice for 30 min to pre-
cipitate high-molecular-weight proteins.
 3. Centrifuge at 20,000 × g for 30 min at 4°C.
 4. Transfer supernatant to a fresh tube and lyophilise in a freeze 
drier until dry.
 5. Resuspend lyophilised extract in 200 ML 0.1% TFA.
 6. Add an equal volume of n-hexane and mix thoroughly to 
remove lipid. Centrifuge at 20,000 × g for 10 min.
 7. Remove the upper lipid-containing fraction and add an equal 
volume of ethyl acetate to the lower water fraction. Centrifuge 
at 20,000 × g for 10 min.
 8. Remove the lower aqueous layer to a clean 1.5-mL tube.
 9. Quantify the protein content by Bradford assay as per the man-
ufacturer’s instructions.
 10. Equalise the protein concentration in a 100 ML volume to 
allow comparative analysis between different treatments.
 11. Run samples on an HPLC using 220 nm as the reference wave-
length for detection of peptide bonds. Where multiple wave-
length analysis is possible, wavelengths of 254 and 280 nm 
should also be used for detection of disulphide bonds and aro-
matic residues, respectively. HPLC gradients should be as 
detailed in Table 2.
 12. If possible, fractionate individual peaks according to the HPLC 
manufacturer’s guidelines (Fig. 6).
 13. Lyophilise individual peaks overnight and store at −20°C until 
tryptic digestion and characterisation by MALDI-ToF or LC/
MS analysis (see Note 24).
Table 2 
HPLC conditions
Time (min) Solvent
 0–5 5% acetonitrile Step and hold
 5–40 5–100% acetonitrile Gradient
40–42 100% acetonitrile Step and hold
42–44 100–5% acetonitrile Gradient
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 1. G. mellonella larvae may be stored in wood shavings in the dark 
at 15°C prior to use. Larvae chosen for experiments should 
weigh between 0.2 and 0.4 g and used within 3–4 weeks of 
receipt. Larvae were discarded if they appeared dark in colour 
due to melanisation.
 2. A range of doses is used to ascertain the lethal dose for differ-
ent C. albicans strains.
 3. The majority of larvae are dead after 96 h.
 4. Larvae that melanise rapidly upon inoculation with a pathogen 
generally do not survive long, while those showing slow or 
little melanisation tend to survive.
 5. Phenyl-3-(2-thiazolyl)-2-thiourea prevents melanisation of the 
haemolymph.
 6. It should be possible to collect approximately 50–60 ML from 
each larva. Ensure all white flocular material is removed; this is 
the fat body and will impede counting.
 7. Haemocyte density varies in response to different pathogens, 
and ascertaining the density can give an indication of the rela-
tive virulence of a pathogen (9).
4. Notes
Fig. 6. Visualisation of G. mellonella antimicrobial peptides following HPLC fractionation.
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 8. Addition of erythromycin to the YEPD plates prevents bacte-
rial growth.
 9. For larvae infected 24 h previously, we generally dilute homo-
genate 1/2,000 in PBS prior to plating. After 24 h at 30°C, 
there are typically 106 colonies per plate.
 10. Virulent pathogens proliferate rapidly in the insect while weak 
or avirulent strains either grow slowly or are eliminated by the 
insect immune response (9).
 11. .We routinely use group sizes of 30, with three plates each 
containing ten larvae.
 12. Antimicrobial drugs can provoke an immune response in lar-
vae so suitable control groups must be included in order to 
assess the actual antimicrobial activity of the test agent (15).
 13. To remove contaminating RNases, glassware should be baked 
at 220°C for 12 h prior to use. Diethyl pyrocarbonate (DEPC) 
is a strong inhibitor of RNases. It can be used at a concentra-
tion of 0.1% (v/v) to treat water, which should be left stirring 
overnight, followed by incubation at 37°C for a minimum of 
4 h prior to sterilisation by autoclaving. DEPC-treated water 
should be used to prepare all buffers required for RNA extrac-
tion. All bottle lids, O-rings, and magnetic stirrers should be 
soaked overnight in DEPC water and autoclaved prior use. All 
chemicals should be weighed without the use of a spatula. 
Gloves must be worn at all times and changed regularly. Pipette 
tips and tubes should be taken from freshly opened bags and 
autoclaved twice prior to use.
 14. Three larvae are required to obtain sufficient RNA for gene 
expression analysis.
 15. Separating gels should be prepared at least 5 h in advance to 
allow better polymerisation of the separating matrix.
 16. To pour a gel, begin by thoroughly washing the glass plates 
with warm soapy water, rinse with 70% ethanol, and dry with 
lint-free tissue paper to remove any residual contamination on 
the glass. The glass plates that we routinely use are 200 mm 
wide and 200 mm long on the front and are 223 mm long at 
the back, and the gels (12.5% acrylamide) poured are approxi-
mately 190 mm × 160 mm and 1.5 mm thick. To prepare suf-
ficient gel solution, mix 60 mL 1.5 M Tris–HCl, 76 mL 
deionised water, 100 mL 30% (w/v) acrylamide, 2.4 mL 10% 
(w/v) SDS, 1.5 mL 10% (w/v) APS, and 60 ML TEMED.
 17. Ensure pieces are no more than 2-mm thick to allow better 
destaining and trypsin absorption.
 18. This usually takes 1 h but may take longer depending on the 
size of the gel piece. This process can be made faster if larger 
pieces are sliced using a clean scalpel.
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 19. Upon addition of the acetonitrile, the gel pieces should turn 
white and shrink.
 20. The 30-min incubation on ice allows the trypsin digestion buf-
fer to penetrate the gel slices and also prevents trypsin auto-
digestion.
 21. The volume added is judged by eye, but it is recommended to 
have at least 0.5 mm above the gel pieces.
 22. . The incubation time is flexible, but the best results are usually 
achieved from an overnight (16 h) incubation.
 23. LC/MS analysis will vary depending on the instrument used 
and the type of sensitivity required for analysis; therefore, it is 
not possible to write a specific protocol for this.
 24. In our studies, we routinely use LC/MS for the characterisa-
tion of proteins.
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